Home > Boards > US Listed > Biotechs > PDL BioPharma Inc. (PDLI)

Any longs out there with a strong opinion

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Ro the Bull Member Profile
 
Followed By 1
Posts 32
Boards Moderated 0
Alias Born 12/07/13
160x600 placeholder
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/13/2020 11:57:44 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/12/2020 12:05:15 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/12/2020 11:48:02 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/5/2020 12:19:28 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 1/15/2020 4:35:32 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/15/2020 12:34:01 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/10/2020 6:38:06 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/10/2020 6:37:41 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/10/2020 6:37:11 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/10/2020 6:36:50 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 1/9/2020 3:27:42 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/23/2019 8:00:01 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/19/2019 8:33:53 AM
PDL BioPharma Announces Upcoming Changes to its Board of Directors PR Newswire (US) - 12/19/2019 8:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/16/2019 8:34:56 AM
PDL BioPharma Board of Directors Increases Share and Note Repurchase Authorization to $275 Million PR Newswire (US) - 12/16/2019 8:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/13/2019 8:34:15 AM
PDL BioPharma to Exchange Approximately 80% of Convertible Notes Due 2021 and 2024 PR Newswire (US) - 12/13/2019 8:30:00 AM
SevenSaoi Capital Supportive of PDL BioPharma Announcement PR Newswire (US) - 12/10/2019 3:10:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/9/2019 8:04:56 AM
PDL BioPharma Announces Completion of Strategic Review Process PR Newswire (US) - 12/9/2019 8:00:00 AM
PDL BioPharma Congratulates Evofem Biosciences on Achieving Major Regulatory and Clinical Milestones with its Lead Product Ca... PR Newswire (US) - 12/3/2019 9:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/19/2019 6:03:21 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/14/2019 1:21:55 PM
PDL BioPharma Reaffirms Commitment To Shareholder Value Creation PR Newswire (US) - 11/14/2019 8:56:00 AM
Ro the Bull   Thursday, 07/24/14 01:17:53 PM
Re: None
Post # of 207 
Any longs out there with a strong opinion on the sustainability/growth of the new revenue stream they're putting together? Looks like they've been getting some lucrative deals, and if they can grow this model a little further as they re-develop a longer term, growing revenue stream... Thanks!

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist